Related Experiment Video
Updated: Jun 11, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Unusual familial cystic kidney disease: combining fine radiologic and genetic evaluation to solve the case
Sylvain Bodard1,2,3,4, Rim Nabbout5, Olivier Hélénon6
1Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. Sylvain.bodard@aphp.fr.
Insights
Accurate diagnosis of autosomal dominant polycystic kidney disease (ADPKD) is vital. This case study shows how advanced imaging and genetic testing are essential to differentiate ADPKD from other cystic kidney diseases, preventing misdiagnosis.
Area of Science:
- Nephrology
- Medical Genetics
- Diagnostic Imaging
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder, causing enlarged kidneys, hypertension, and extrarenal complications.
- Accurate diagnosis is crucial for prognosis, treatment, and family counseling, especially when differentiating from other cystic kidney diseases without a clear family history.
- Advanced molecular genetics and imaging are key tools for diagnosing ADPKD and assessing patient and family prognosis.
Purpose of the Study:
- To highlight the diagnostic complexities in suspected Autosomal dominant polycystic kidney disease (ADPKD) cases.
- To emphasize the necessity of comprehensive diagnostic approaches, including advanced imaging and genetic analysis, to prevent misdiagnosis.
- To illustrate the variability in presentation and genetic findings within families affected by or suspected of having ADPKD.
Main Methods:
- Case study analysis of three patients from the same family with suspected Autosomal dominant polycystic kidney disease (ADPKD).
- Utilized ultrasound and Magnetic Resonance Imaging (MRI) for renal assessment.
- Conducted genetic testing to identify mutations, specifically in the PKD1 gene.
Main Results:
- Initial ultrasound suggested ADPKD in two older patients, but MRI and genetic testing ruled out the disease.
- The younger patient presented with characteristic enlarged kidneys and cysts, with genetic testing confirming a deleterious PKD1 mutation, likely a de novo mutation.
- Demonstrated significant variability in diagnostic findings within the same family, underscoring the limitations of initial assessments.
Conclusions:
- Thorough diagnostic processes involving detailed imaging and genetic analyses are essential to prevent misdiagnosis of Autosomal dominant polycystic kidney disease (ADPKD).
- Initial clinical presentation and imaging can be misleading, necessitating further investigation to avoid inappropriate treatment and patient/family stress.
- Accurate diagnosis through comprehensive assessments is critical for effective treatment decisions and precise familial genetic counseling regarding renal cystic disorders.
Background:
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disease, characterized by enlarged kidneys with numerous cysts, high blood pressure, and a variety of extrarenal complications. This disease is a significant cause of renal failure and requires accurate differentiation from other cystic kidney diseases, especially when family history does not clearly indicate ADPKD. This is crucial due to differences in prognosis, treatment, and familial implications. Advanced molecular genetics and imaging techniques are employed to diagnose and assess the prognosis of patients and their families.
Case Presentation:
The case study revolves around three patients from the same family-two sisters and one daughter-referred to a nephrology department for ADPKD management. The initial proband, a 42-year-old woman, experienced abdominal discomfort leading to an ultrasound that suggested ADPKD. However, MRI findings indicated standard-sized kidneys with bilateral parapelvic cysts, and no genetic markers for ADPKD were found. Her sister, presenting with controlled hypertension and similar ultrasound findings, also had her initial ADPKD diagnosis refuted by MRI and genetic testing, which revealed no significant mutations. The daughter, however, exhibited a different scenario with enlarged kidneys and multiple cysts characteristic of early-stage ADPKD. Genetic testing confirmed a deleterious PKD1 mutation, suggesting a de novo mutation, as her father showed no signs of the disease.
Conclusion:
This study highlights the complexity and necessity of thorough diagnostic processes in suspected ADPKD cases to prevent misdiagnosis. The initial symptoms and imaging might misleadingly suggest ADPKD, as seen in the cases of the two older patients. Still, further detailed imaging and genetic analyses revealed no ADPKD, preventing inappropriate treatment and stress. In contrast, the younger patient's distinctive clinical and genetic profile confirmed ADPKD, illustrating the variability within even closely related individuals. Such detailed assessments are crucial in guiding correct treatment decisions and providing accurate familial counseling, emphasizing the importance of considering a broader spectrum of renal cystic disorders before confirming a diagnosis of ADPKD.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi III: Medical Management
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management

